Plumbane, tetraethyl-
RTECS #
TP4550000
CAS #
Updated
March 2018
Molecular Weight
323.47
Molecular Formula
C8H20Pb
Synonyms
Czteroetylek olowiu (Polish)
Lead, tetraethyl-
NCI-C54988
NSC 22314
Piombo tetra-etile (Italian)
RCRA waste number P110
TEL
Tetraethyl lead
Tetraethyl lead (ACGIH:OSHA)
Tetraethylolovo (Czech)
Tetraethylplumbane
Tetraethylplumbium
Lead, tetraethyl-
NCI-C54988
NSC 22314
Piombo tetra-etile (Italian)
RCRA waste number P110
TEL
Tetraethyl lead
Tetraethyl lead (ACGIH:OSHA)
Tetraethylolovo (Czech)
Tetraethylplumbane
Tetraethylplumbium
Mutation Data and Reference
System Test | Route/Organism/Tissue | Dose | Reference |
---|---|---|---|
morphological transform | embryo/hamster | 12500 µg/L | AETODY 1,241,1980 |
Reproductive Effects Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
intraperitoneal/rat | 3 mg/kg (14D pregnant) | Reproductive: Effects on newborn: Biochemical and metabolic | BNEOBV 58,41,1990 |
intraperitoneal/rat | 1499 µg/kg (13D pregnant) | Reproductive: Specific developmental abnormalities: Central nervous system Reproductive: Specific developmental abnormalities: Hepatobiliary system | VHTODE 34,510,1992 |
intraperitoneal/rat | 3 mg/kg (19D pregnant) | Reproductive: Specific developmental abnormalities: Central nervous system Reproductive: Specific developmental abnormalities: Hepatobiliary system Reproductive: Specific developmental abnormalities: Urogenital system | VHTODE 34,510,1992 |
oral/mouse | 11 mg/kg (5-15D pregnant) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | FCTXAV 13,629,1975 |
oral/rat | 11 mg/kg (6-16D pregnant) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | FCTXAV 13,629,1975 |
oral/rat | 7500 µg/kg (12-14D pregnant) | Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | TXAPA9 21,265,1972 |
Tumorigenic Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
subcutaneous/mouse | lowest published toxic dose: 100 mg/kg/21D- intermittent | Tumorigenic: Carcinogenic by RTECS criteria Liver: Tumors Blood: Lymphoma including Hodgkin's disease | EXPEAM 24,580,1968 |
Acute Toxicity Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
inhalation/human | lowest published toxic concentration: 1749 gm/m3/30M | Olfaction: Other olfaction effects Eye: Lacrimation Gastrointestinal: Nausea or vomiting | SAIGBL 17,223,1975 |
inhalation/mouse | Lowest published lethal concentration: 650 mg/m3/7H | SAIGBL 15,3,1973 | |
inhalation/mouse | lethal concentration (50 percent kill): 48.52 mg/m3/2H | TPKVAL 9,7,1967 | |
inhalation/mouse | lethal concentration (50 percent kill): 3.5 ppm/2H | TPKVAL 9,7,1967 | |
inhalation/rat | lethal concentration (50 percent kill): 850 mg/m3/1H | Behavioral: Excitement Lung, Thorax, or Respiration: Cyanosis | BJIMAG 18,277,1961 |
intraperitoneal/rat | lethal dose (50 percent kill): 15 mg/kg | MELAAD 54,486,1963 | |
intravenous/rabbit | lowest published lethal dose: 22 mg/kg | EQSSDX 1,1,1975 | |
intravenous/rat | lethal dose (50 percent kill): 14400 µg/kg | MELAAD 54,486,1963 | |
oral/rabbit | lowest published lethal dose: 30 mg/kg | SAIGBL 15,3,1973 | |
oral/rat | lethal dose (50 percent kill): 12300 µg/kg | Behavioral: Altered sleep time (including change in righting reflex) Behavioral: Convulsions or effect on seizure threshold Behavioral: Aggression | EXPEAM 28,923,1972 |
parenteral/rat | lethal dose (50 percent kill): 15 mg/kg | AOHYA3 3,226,1961 | |
skin/Dog | lowest published lethal dose: 547 mg/kg | SAIGBL 15,3,1973 | |
skin/guinea pig | lowest published lethal dose: 995 mg/kg | SAIGBL 15,3,1973 | |
skin/rabbit | lowest published lethal dose: 830 mg/kg | SAIGBL 15,3,1973 | |
subcutaneous/mouse | lethal dose (50 percent kill): 13020 µg/kg | Behavioral: Tremor Behavioral: Convulsions or effect on seizure threshold Behavioral: Convulsions or effect on seizure threshold | FKIZA4 49,2779,1958 |
subcutaneous/rabbit | lowest published lethal dose: 32 mg/kg | EQSSDX 1,1,1975 | |
unreported route/man | lowest published lethal dose: 1470 µg/kg | 85DCAI 2,73,1970 |
Other Multiple Dose Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
inhalation/rat | lowest published toxic concentration: 1100 mg/m3/1H/5D- intermittent | Brain and Coverings: Other degenerative changes Behavioral: Convulsions or effect on seizure threshold Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | NTIS** OTS0533656-1 |
intravenous/monkey | lowest published toxic dose: 42 mg/kg/7D- intermittent | Behavioral: Food intake (animal) Kidney, Ureter, and Bladder: Other changes in urine composition Nutritional and Gross Metabolic: Weight loss or decreased weight gain | TOLED5 2,187,1978 |
oral/mouse | lowest published toxic dose: 10 mg/kg/5D- intermittent | Behavioral: Tremor | NTPTR* NTR-IMM-20009 |
oral/mouse | lowest published toxic dose: 14 mg/kg/14D- intermittent | Blood: Normocytic anemia Blood: Luekopenia Blood: Changes in erythrocyte (RBC) count | NTPTR* IMM-20009 |
oral/mouse | lowest published toxic dose: 14 mg/kg/14D- intermittent | Liver: Hepatitis (hepatocellular necrosis), diffuse Kidney, Ureter, and Bladder: Renal function tests depressed Immunological Including Allergic: Decrease in cellular immune response | NTPTR* IMM-20009 |
oral/mouse | lowest published toxic dose: 14 mg/kg/14D- intermittent | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Immunological Including Allergic: Decreased immune response | NTPTR* IMM-20009 |
oral/rat | lowest published toxic dose: 2520 µg/kg/6W- continuous | Endocrine: Other changes | JANSY* 8,287,1983 |
skin/Dog | lowest published toxic dose: 504 µL/kg/21D- intermittent | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | FKIZA4 49,2779,1958 |
Reviews
Organization | Standard | Reference |
---|---|---|
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-time-weighted average 0.1 mg(Pb)/m3 (skin) | DTLVS* TLV/BEI,2013 |
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-Not classifiable as a human carcinogen | DTLVS* TLV/BEI,2013 |
International Agency for Research on Cancer (IARC) | Cancer Review:Human Inadequate Evidence | IMSUDL 7,230,1987 |
International Agency for Research on Cancer (IARC) | Cancer Review:Animal Inadequate Evidence | IMEMDT 23,325,1980 |
International Agency for Research on Cancer (IARC) | Cancer Review:Group 3 | IMSUDL 7,230,1987 |
TOXICOLOGY REVIEW | JORCAI 76,265,1974 | |
TOXICOLOGY REVIEW | JAMAAP 105,578,1935 | |
TOXICOLOGY REVIEW | FCTXAV 9,105,1971 | |
TOXICOLOGY REVIEW | AJMEAZ 38,409,1965 | |
TOXICOLOGY REVIEW | 85DHAX Pb,255,1972 | |
TOXICOLOGY REVIEW | IMEMDT 87,225, | |
TOXICOLOGY REVIEW | NCLNA* 16,503,1998 | |
TOXICOLOGY REVIEW | NBREV* 26,81,2002 | |
TOXICOLOGY REVIEW | MUREAV 762,76,2014 | |
TOXICOLOGY REVIEW | MUREAV 770,119,2016 |
Standards and Regulations
Organization | Standard | Reference |
---|---|---|
Mine Safety and Health Administration (MSHA) STANDARD-air | time-weighted average 0.1 mg(Pb)/m3 (skin) | DTLVS* 3,251,1971 |
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN check ACGIH TLV; | ||
Occupational Exposure Limit IN SINGAPORE, VIETNAM check ACGIH TLV | ||
Occupational Exposure Limit-ARAB Republic of Egypt | time-weighted average 0.1 mg/m3, JAN1993 | |
Occupational Exposure Limit-AUSTRALIA | time-weighted average 0.1 mg(Pb)/m3, JUL2008 | |
Occupational Exposure Limit-AUSTRIA | MAK-TMW 0.05 mg/m3;KZW 0.2 mg/m3, skin, 2007 | |
Occupational Exposure Limit-BELGIUM | time-weighted average 0.1 mg(Pb)/m3, Skin, MAR2002 | |
Occupational Exposure Limit-DENMARK | time-weighted average 0.007 ppm (0.05 mg(Pb)/m3), skin, MAY2011 | |
Occupational Exposure Limit-FINLAND | time-weighted average 0.075 mg(Pb)/m3, short term exposure limit 0.23 mg(Pb)/m3, skin, NOV2011 | |
Occupational Exposure Limit-FRANCE | VME 0.1 mg(Pb)/m3, Skin, FEB2006 | |
Occupational Exposure Limit-GERMANY | MAK 0.05 mg(Pb)/m3, skin, 2011 | |
Occupational Exposure Limit-HUNGARY | time-weighted average 0.05 mg/m3, short term exposure limit 0.2 mg/m3, Skin, SEP2000 | |
Occupational Exposure Limit-ICELAND | time-weighted average 0.05 mg/m3, skin, NOV2011 | |
Occupational Exposure Limit-JAPAN | Occupational Exposure Limit 0.075 mg(Pb)/m3, skin, MAY2012 | |
Occupational Exposure Limit-KOREA | time-weighted average 0.075 mg/m3, skin, 2006 | |
Occupational Exposure Limit-MEXICO | time-weighted average 0.1 mg(Pb)/m3;short term exposure limit 0.3 mg(Pb)/m3 (skin), 2004 | |
Occupational Exposure Limit-NEW ZEALAND | time-weighted average 0.1 mg(Pb)/m3, skin, JAN2002 | |
Occupational Exposure Limit-NORWAY | time-weighted average 0.001 ppm (0.075 mg/m3), JAN1999 | |
Occupational Exposure Limit-PERU | time-weighted average 0,1 mg/m3, JUL2005 | |
Occupational Exposure Limit-POLAND | MAC(time-weighted average) 0.05 mg/m3, MAC(short term exposure limit) 0.1 mg/m3, JAN1999 | |
Occupational Exposure Limit-RUSSIA | short term exposure limit 0.005 mg/m3, Skin, JUN2003 | |
Occupational Exposure Limit-SWEDEN | time-weighted average 0.05 mg(Pb)/m3;short term exposure limit 0.2 mg(Pb)/m3, Skin, JUN2005 | |
Occupational Exposure Limit-SWITZERLAND | MAK-week 0.05 mg/m3, KZG-week 0.1 mg/m3, skin, JAN2011 | |
Occupational Exposure Limit-THAILAND | time-weighted average 0.075 mg/m3, JAN1993 | |
Occupational Exposure Limit-THE NETHERLANDS | MAC-TGG 0.05 mg/m3, Skin, 2003 | |
Occupational Exposure Limit-THE PHILIPPINES | time-weighted average 0.075 mg/m3, Skin, JAN1993 | |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction) | 8H time-weighted average 0.1 mg(Pb)/m3 (skin) | CFRGBR 29,1926.55,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors) | 8H time-weighted average 0.075 mg(Pb)/m3 | CFRGBR 41,50-204.50,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry) | 8H time-weighted average 0.075 mg(Pb)/m3 (skin) | CFRGBR 29,1910.1000,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards) | 8H time-weighted average 0.1 mg(Pb)/m3 (skin) | CFRGBR 29,1915.1000,1993 |
NIOSH Documentation and Surveillance
Organization | Standard | Reference |
---|---|---|
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO TETRAETHYLLEAD (as Pb)-air | 10H time-weighted average 0.075 mg/m3 (Sk) | NIOSH* DHHS #92-100,1992 |
National Occupational Exposure Survey 1983 | Hazard Code 71640; Number of Industries 6; Total Number of Facilities 729; Number of Occupations 15; Total Number of Employees Exposed 36802; Total Number of Female Employees Exposed 1099 | |
National Occupational Hazard Survey 1974 | Hazard Code 71640; Number of Industries 1; Total Number of Facilities 85; Number of Occupations 6; Total Number of Employees Exposed 799 |
Status in Federal Agencies
Page last reviewed: November 16, 2018
Content
source: National Institute for Occupational Safety and Health